Viewing nowCombinationSiren Tablets
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Person Co., Ltd.

MFDS item code 201707215 · Approved 2017.09.22
Treatment of acid-related disorders (gastric ulcer, gastritis, etc.) and prevention of Mendelson syndrome
This medication is used to treat various gastrointestinal diseases such as ulcers in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It can also be administered prior to anesthesia to prevent Mendelson syndrome and is effective for treating ulcers after surgery. It can be used for gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps to treat multiple gastrointestinal disorders and improve symptoms.
Usually, take 2 tablets orally twice daily, in the morning and at bedtime, irrespective of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination therapy to treat ulcers caused by NSAID use or to prevent gastric and duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, and other ulcers usually heal within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to take 2 tablets on the night before surgery.
This medication should not be used in patients with poor kidney function or those undergoing dialysis. Patients with a history of allergic reactions to this medication or its ingredients should avoid administration. Patients with a history of acute porphyria may experience worsening symptoms with this medication and should not use it. Patients who have had gastrointestinal surgery or are pregnant or could become pregnant, as well as premature infants and newborns, should not be administered this medication for safety reasons. Patients on a dietary regimen that restricts potassium intake should use this medication with caution. Patients with impaired liver function, a history of drug allergies, elderly patients, and those with previous kidney issues need to exercise extra caution when using this drug. If used in conjunction with non-steroidal anti-inflammatory drugs, regular check-ups are necessary, especially in elderly patients or those with a history of peptic ulcers. This medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age with recent dyspepsia should start treatment only after confirming malignancy. Patients with Helicobacter pylori infections and ulcers in the stomach or duodenum must undergo bacterial eradication therapy. In critically ill patients receiving treatment in an intensive care unit, caution is required as this medication may cause gastric stones. The aluminum content of this drug may interfere with phosphate absorption, so it should be administered cautiously in patients with hypophosphatemia. Patients who have difficulty swallowing may experience respiratory complications after taking this medication, requiring caution. While using this medication, severe allergic reactions such as anaphylactic shock may occur infrequently, and if symptoms arise, administration must be stopped immediately, and appropriate treatment sought. If allergic symptoms such as skin rash, urticaria, angioedema, fever, bronchospasm, hypotension, or chest pain occur, the medication should be discontinued. Abnormal blood test results may occur, so if symptoms like fatigue, bleeding, or fever appear, immediate testing should be conducted, and drug discontinuation may be necessary if warranted. Deterioration of liver function can lead to hepatitis or jaundice, so if such symptoms appear, intake should be stopped immediately. Cardiac arrhythmias or vasculitis have been reported rarely, requiring caution if cardiac-related symptoms present. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and feces color may change but does not require specific treatment. Dizziness, drowsiness, confusion, seizures, insomnia, headache, heaviness, malaise, anxiety, mental confusion, depression, hallucinations, blurred vision, involuntary movement disorders, gynecomastia, galactorrhea, erectile dysfunction, and decreased libido may occur rarely, particularly in patients with poor kidney function. Endocrine symptoms such as gynecomastia or sexual dysfunction have been reported rarely, though the causal relationship is unclear. Myalgia or arthralgia, and in severe cases, rhabdomyolysis may present, requiring discontinuation upon unusual symptoms. Skin rashes, erythema multiforme, and hair loss may occur rarely. If used for a prolonged period without effect, it is advisable to switch to a different medication, and regular tests of blood, liver, and kidney function should be conducted. Elderly patients, patients with chronic lung disease, diabetic patients, and immunocompromised patients may have an increased risk of pneumonia and should exercise caution. If dizziness or drowsiness occur during administration, driving or operating dangerous machinery should be avoided. This drug can interact with others, so always consult healthcare providers regarding concomitant medications. It is safest for pregnant or breastfeeding women to not use this medication. Safety and efficacy in pediatrics have not been established, so it is advisable not to administer it to children. In case of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and blood dialysis can be performed if needed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.
Green round film-coated tablets
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Person Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.